Trial Profile
Dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Therapeutic Use
- 01 Aug 2021 Status has been changed to completed as per Netherlands Trial Register
- 28 Nov 2014 New trial record